Nature's Way Kids Smart Calcium + Vitamin D3

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

calcium hydrogen phosphate,colecalciferol

Available from:

Pharmacare Laboratories Pty Ltd

INN (International Name):

calcium hydrogen phosphate,colecalciferol

Class:

Medicine Listed

Authorization status:

Listed

Patient Information leaflet

WARNINGS
LIMITATIONS OF USE
Rikodeine should only be used when your doctor or pharmacist decides
that other treatment options are not able to effectively
manage your cough, or you cannot tolerate them.
HAZARDOUS AND HARMFUL USE
Rikodeine poses risks of abuse, misuse and addiction which can lead to
overdose and death.
LIFE THREATENING RESPIRATORY DEPRESSION
Rikodeine can cause life-threatening or fatal breathing problems
(slow, shallow, unusual or no breathing) even when used as
recommended. These problems can occur at any time during use, but the
risk is higher when first starting Rikodeine and after a
dose increase, if you are older, or have an existing problem with your
lungs.
USE OF OTHER MEDICINES WHILE USING RIKODEINE
USING RIKODEINE WITH OTHER MEDICINES THAT CAN MAKE YOU FEEL DROWSY
SUCH AS SLEEPING TABLETS (E.G., BENZODIAZEPINES),
OTHER PAIN RELIEVERS, ANTIHISTAMINES, ANTIDEPRESSANTS, ANTIPSYCHOTICS,
GABAPENTINOIDS (E.G., GABAPENTIN AND PREGABALIN),
CANNABIS AND ALCOHOL MAY RESULT IN SEVERE DROWSINESS, DECREASED
AWARENESS, BREATHING PROBLEMS, COMA AND DEATH.
You must not drink alcohol while using Rikodeine.
RIKODEINE
® ORAL LIQUID
(rye-co-deen)
R
I
K
O
D
E
I
N
E
O
R
A
L
L
I
Q
U
I
D
ACTIVE INGREDIENT(S): _Dihydrocodeine tartrate and sorbitol
(die-hydro-co-deen tahr-treyt + sore-be-tol)_
CONSUMER MEDICINE INFORMATION (CMI)
This leaflet provides important information about using
Rikodeine. YOU SHOULD ALSO SPEAK TO YOUR DOCTOR OR
PHARMACIST IF YOU WOULD LIKE FURTHER INFORMATION OR IF YOU
HAVE ANY CONCERNS OR QUESTIONS ABOUT USING RIKODEINE.
WHERE TO FIND INFORMATION IN THIS LEAFLET:
1. Why am I taking Rikodeine?
2. What should I know before I take Rikodeine?
3. What if I am taking other medicines?
4. How do I take Rikodeine?
5. What should I know while taking Rikodeine?
6. Are there any side effects?
7. Product details
1.
WHY AM I TAKING RIKODEINE?
Rikodeine is a cough suppressant and contains the active
ingredients, dihydrocodeine tartrate and sorbitol.
Rikodeine is used to give temporary relief for an unpro

Summary of Product characteristics

1
AUSTRALIAN PRODUCT INFORMATION –
RIKODEINE
®
(DIHYDROCODEINE TARTRATE AND SORBITOL) ORAL LIQUID
1
NAME OF THE MEDICINE
Dihydrocodeine tartrate and Sorbitol.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 10 mL of Rikodeine Oral Liquid contains dihydrocodeine tartrate
19 mg, and sorbitol 4.4 g. It also
contains sucrose, citric acid, methyl hydroxybenzoate, amaranth,
strawberry flavour 73858 and water.
Excipients with known effects: sugars, hydroxybenzoates, sorbitol
(26.4 g per 60 mL (maximum
recommended daily dose).
3
PHARMACEUTICAL FORM
Oral liquid – pink coloured solution
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
For relief of stubborn, unproductive cough.
4.2
D
OSE AND METHOD OF ADMINISTRATION
AGE
DOSAGE
HOW OFTEN
Adults and Children 12 years and over
5 to 10 mL
Every 4-6
hours
as
required
Children between 6-11 years
Use in children ages 6-11 years only on the advice of a doctor,
pharmacist or nurse practitioner
2.5 to 5 mL
Do not use in children aged less than 6 years
Initial dosage should be reduced in the elderly as there may be a
marked variability in pharmacokinetics in
the elderly (See _Metabolism and Excretion in section 5.2
Pharmacokinetic Properties_).
WARNINGS
HAZARDOUS AND HARMFUL USE
Rikodeine Oral Liquid contains dihydrocodeine and poses risks of
hazardous and harmful use which can
lead to overdose and death. Assess the patient’s risk of hazardous
and harmful use before prescribing and
monitor the patient regularly during treatment (see _section 4.4.
Special Warnings and Precautions for Use_).
LIFE THREATENING RESPIRATORY DEPRESSION
Serious, life-threatening or fatal respiratory depression may occur
with the use of Rikodeine Oral Liquid.
Be aware of situations which increase the risk of respiratory
depression, modify dosing in patients at risk
and monitor patients closely, especially on initiation or following a
dose increase (see _section 4.4 Special _
_Warnings and Precautions for Use_).
CONCOMITANT USE OF BENZODIAZEPINES AND OTHER CENTRAL NERVOUS SYSTEM
(CNS) DEPRESSANTS,
IN